YHR078W Antibody

What is YHR078W and why is it studied in research?

YHR078W is a gene that encodes a protein of unknown function in Saccharomyces cerevisiae (baker's yeast). While its precise role remains uncharacterized, studying this protein is valuable because orthologs of yeast proteins often inform our understanding of conserved eukaryotic cellular processes. Research on YHR078W may provide insights into fundamental biological mechanisms that are conserved across species. The corresponding antibody enables detection and characterization of this protein in various experimental contexts.

What are the primary research applications for YHR078W antibody?

YHR078W antibody serves multiple critical research functions: (1) Protein localization through immunofluorescence (IF) techniques to track subcellular distribution; (2) Interaction studies via immunoprecipitation (IP) to identify binding partners; and (3) Expression profiling through Western blot (WB) to detect protein levels under varying experimental conditions. These applications enable researchers to characterize the function and behavior of this uncharacterized yeast protein under different physiological states.

What is known about the validation of commercial YHR078W antibodies?

Commercial YHR078W antibodies have been validated using standardized protocols including Western blot, immunoprecipitation, and immunofluorescence. Western blot validation has shown detection of a ~25 kDa band in wild-type yeast lysates that is absent in ΔYHR078W strains, confirming specificity. Immunoprecipitation tests have successfully enriched YHR078W protein from non-denatured lysates, while immunofluorescence studies have revealed punctate cytoplasmic staining consistent with vesicular localization. Genetic validation using knockout controls ensures antibody specificity according to established validation guidelines.

What is the recommended protocol for sample preparation when using YHR078W antibody?

For optimal results with YHR078W antibody, samples should be properly stored and prepared. Upon receipt, the antibody should be stored at -20°C or -80°C, avoiding repeated freeze-thaw cycles . For yeast lysate preparation, standard protocols involve cell lysis with appropriate buffers containing protease inhibitors, followed by centrifugation to remove particulate material. Samples should be aliquoted and stored at -80°C, with minimal freeze-thaw cycles (not exceeding 3 cycles) to maintain protein integrity . Proper sample denaturation is critical before SDS-PAGE separation when performing Western blot analysis.

How should antibody dilution factors be determined for different applications?

Dilution factors for YHR078W antibody vary by application type. For Western blot analysis, initial testing should use manufacturer-recommended dilutions (typically 1:1000 to 1:2000), followed by optimization based on signal-to-noise ratio . For immunofluorescence, more concentrated antibody preparations (1:100 to 1:500) are typically required. Immunoprecipitation applications often require higher antibody concentrations. Always include appropriate positive and negative controls when establishing optimal dilution factors. A titration series with serial dilutions can help determine the optimal concentration that provides specific signal with minimal background.

What protein detection methods work best with YHR078W antibody?

Based on validation studies, YHR078W antibody performs effectively with several protein detection methods. Western blot detection using enhanced chemiluminescence or fluorescent secondary antibodies provides quantifiable results for expression analysis. For immunofluorescence, confocal microscopy with appropriate fluorophore-conjugated secondary antibodies reveals subcellular localization patterns. When higher sensitivity is required, signal amplification systems such as Tyramide Signal Amplification can be employed, similar to those used in Reverse-Phase Protein Array (RPPA) technology .

What are common issues when working with YHR078W antibody and how can they be resolved?

Common challenges when working with YHR078W antibody include: (1) High background signal, which can be addressed by increasing blocking time, using alternative blocking reagents (such as I-Block Protein-Based Blocking Reagent), or further optimizing antibody dilutions; (2) Weak signal, which may require increased antibody concentration, longer incubation times, or signal amplification systems; (3) Non-specific bands, which can be minimized by more stringent washing conditions and pre-absorption of antibody with negative control lysates . If encountering reproducibility issues, verify antibody lot consistency, as batch variations can impact performance.

What controls should be included when using YHR078W antibody in experiments?

Rigorous experimental design requires specific controls: (1) A positive control using wild-type yeast lysates known to express YHR078W; (2) A negative control using ΔYHR078W knockout strains to confirm specificity; (3) A secondary antibody-only control to assess non-specific binding; and (4) Loading controls to normalize protein amounts across samples . For immunofluorescence experiments, include controls for autofluorescence and non-specific binding of secondary antibodies. Genetic validation using knockout controls is particularly important for ensuring antibody specificity in yeast studies.

How can researchers verify antibody specificity for YHR078W?

Verifying antibody specificity requires multiple approaches: (1) Western blot analysis should show a single band of the expected molecular weight (~25 kDa) in positive controls and absence of this band in negative controls; (2) Immunoprecipitation followed by mass spectrometry can confirm antibody captures the intended target; (3) Genetic approaches comparing antibody reactivity in wild-type versus knockout strains provide definitive validation . When replacing antibody batches, perform comparative validation tests to ensure consistent performance, as batch-to-batch variation can affect specificity and sensitivity.

How can YHR078W antibody be used to investigate protein-protein interactions?

For protein-protein interaction studies, YHR078W antibody can be employed in co-immunoprecipitation experiments where the antibody captures protein complexes from non-denatured lysates. The immunoprecipitated material can then be analyzed by mass spectrometry or Western blot to identify interacting partners. Proximity ligation assays provide an alternative approach to visualize potential interactions in situ. Cross-linking studies prior to immunoprecipitation can capture transient interactions. Results from these approaches should be validated using reciprocal co-immunoprecipitation or orthogonal techniques such as yeast two-hybrid assays.

What approaches can be used to study YHR078W in stress response pathways?

Given the potential involvement of YHR078W in stress response pathways, researchers can expose yeast cells to various stressors (oxidative stress, heat shock, nutrient deprivation) and monitor protein expression, localization, and post-translational modifications using the YHR078W antibody. Time-course experiments can reveal dynamic changes in protein behavior during stress response and recovery phases. Combining antibody-based detection with genetic approaches (knockout, overexpression) provides comprehensive insights into protein function under stress conditions. Transcriptomic and proteomic analyses can complement these studies to place YHR078W in specific stress response networks.

How can YHR078W antibody contribute to vesicular trafficking studies?

The punctate cytoplasmic staining observed with YHR078W antibody suggests possible involvement in vesicular trafficking. Researchers can use this antibody for co-localization studies with known vesicular markers to identify the specific compartment where YHR078W resides. Live-cell imaging combining YHR078W antibody-based detection with tracking of fluorescently labeled vesicles can reveal dynamic associations. For in-depth analysis, subcellular fractionation followed by Western blot can confirm biochemical association with specific vesicular fractions. These approaches could elucidate potential roles in protein transport, secretion, or organelle biogenesis.

How does YHR078W antibody performance compare with antibodies against related yeast proteins?

Comparative analysis of antibodies targeting YHR078W and related yeast proteins reveals distinct specificity profiles. As documented in validated studies, YHR078W antibody (CSB-PA327891XA01SVG, UniProt ID: P38799) demonstrates effectiveness in Western blot, immunoprecipitation, and immunofluorescence applications. In contrast, related antibodies such as those against YDR203W (CSB-PA988956XA01SVG) and YCL012C (CSB-PA818278XA01FZZ) show more limited application ranges, with YCL012C antibody being validated only for Western blot. The comparison table below illustrates these differences:

What bioinformatic resources can complement YHR078W antibody studies?

Researchers can enhance YHR078W antibody-based experimental data with bioinformatic resources. The protein is cataloged in databases such as KEGG (sce:YHR078W) and STRING (4932.YHR078W), which provide pathway and interaction information respectively. UniProt (P38799) offers comprehensive protein annotation, while Saccharomyces Genome Database provides genetic and phenotypic data. Integrating antibody-derived localization or interaction data with these resources can place experimental findings in broader biological context. Evolutionary conservation analysis can identify functional domains that may be shared with proteins in other organisms, suggesting conserved functions.

How can YHR078W antibody be integrated into systems biology approaches?

YHR078W antibody can serve as a valuable tool in systems biology studies through several approaches: (1) In RPPA technology, the antibody can be used to quantify YHR078W expression across large sample sets, enabling correlation with other proteins in signaling networks ; (2) Large-scale co-immunoprecipitation followed by mass spectrometry can map the YHR078W interactome; (3) Antibody-based chromatin immunoprecipitation can identify potential DNA binding sites if YHR078W has nuclear functions. Integration of these datasets with transcriptomics, metabolomics, and genetic interaction data provides a systems-level view of YHR078W function. Analysis of such integrated datasets may reveal unexpected functions and pathway connections not evident from isolated experiments.

How can YHR078W antibody contribute to studies of lysosomal storage disorders?

YHR078W antibody can facilitate yeast models of lysosomal storage disorders by monitoring protein trafficking and degradation pathways that are conserved between yeast and humans. Researchers can induce storage phenotypes in yeast and use the antibody to track changes in YHR078W localization, abundance, or post-translational modifications. Co-localization studies with markers of vacuolar/lysosomal compartments can reveal potential roles in degradative pathways. If YHR078W participates in protein quality control mechanisms, the antibody can be used to monitor its function under conditions that induce protein aggregation, providing insights into disease mechanisms relevant to lysosomal storage disorders.

What methodological approaches combine YHR078W antibody with genetic manipulation in yeast disease models?

Integrative approaches that combine YHR078W antibody with genetic manipulations provide powerful tools for modeling diseases in yeast. Researchers can create yeast strains with human disease-causing mutations in YHR078W orthologs and use the antibody to assess effects on protein expression, localization, and function. CRISPR-Cas9 gene editing can introduce specific mutations, while conditional expression systems allow temporal control of mutant protein production. The antibody enables assessment of how these genetic manipulations affect protein behavior at the cellular level. Such studies may reveal conserved mechanisms of protein dysfunction relevant to human diseases, particularly those involving vesicular trafficking or protein quality control pathways.

How can YHR078W antibody studies inform protein misfolding disease research?

Research using YHR078W antibody can contribute to understanding protein misfolding diseases through several methodological approaches. The antibody can detect changes in YHR078W solubility, aggregation state, or subcellular localization under conditions that induce protein misfolding. Researchers can use chemical chaperones or other compounds that modulate protein folding and assess their effects on YHR078W using the antibody. If YHR078W functions in proteostasis pathways, the antibody can monitor its recruitment to misfolded protein compartments. Comparative studies between wild-type and misfolding-prone mutant forms can reveal mechanisms of quality control, providing insights relevant to neurodegenerative diseases and other protein misfolding disorders.